Shenshang Xingye Fund
1
61M
1
1
- Areas of investment
Summary
Among the various public portfolio startups of the fund, we may underline Genetron Health Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Medical Device.
The top activity for fund was in 2018. The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Shenshang Xingye Fund, startups are often financed by Zhongyuan Union Cell & Gene Eng, Share Capital, New Horizon Capital. The meaningful sponsors for the fund in investment in the same round are Zhongjin Kangrui Medical Industrial Fund, V Star Capital. In the next rounds fund is usually obtained by Vivo Capital, Highlight Capital, Alexandria Venture Investments.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Clinical Trials (1)
- Medical Device (1)
- Medical (1)
- Health Care (1)
- Investments by region
-
- China (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Genetron Health | 04 Jan 2018 | Health Care, Medical Device, Medical, Clinical Trials | Late Stage Venture | 61M | Beijing, Dongcheng District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.